Ortega SMF, Manríquez RA, Castañeda ZA, Sáenz CC, Toussaint CS, Vega MME

Language: Spanish
References: 19
Page: 258-261
PDF size: 186.44 Kb.

ABSTRACT

We present a case of a male patient with eruptive clear cell syringomas associated to diabetes mellitus. Syringomas are frequent benign tumors originated from the eccrine glands. The eruptive subtype is infrequent and is characterized by the abrupt onset of disseminated syringomas mainly affecting anterior and posterior thorax, axillae and abdomen. On the other hand, the histopathological variant of clear cell syringomas is rare and its association with diabetes mellitus is controversial.

REFERENCES

1. Soler-Carrillo J, Estrach T y Mascar JM, Eruptive syringoma: 27 new cases and review of the literature, jeadv 2001; 15:242-6.

2. Nakabayashi Y, Miinura M y Hori Y, A case of clear cell syringoma, Rinsho Dermatol 1980; 22:599-603.

3. Saitoh A, Ohtake N, Fukuda S y Tamaki K, Clear cells of eccrine glands in a patient with clear cell syringoma associated with diabetes mellitus, Am J Dermatopathol 1993; 15:166-8.

4. Guitart J, Rosenbaum MM y Requena L, “Eruptive syringoma”: a misnomer for a reactive eccrine glandular ductal proliferation?, J Cutan Pathol 2003; 30:202-5.

5. Reyes-Morelo MT, Morichelli M, Rodríguez-Cabral A y Stella I, Siringomas: presentación de casos clínicos y revisión de la bibliografía, Arch Argent Dermatol 2015; 65:1-8.

6. Ciarloni L, Frouinb E, Bodinc F y Cribier B, Syringoma: a clinicopathological study of 244 cases, Ann Dermatol Venereol 2016; 143:521-8.

7. Ong GC, Lim KS y Chian LY, Eruptive syringoma in a patient with trisomy 21, Singapore Med J 2010; 51:e46-7.

8. Wallace ML y Smoller BR, Progesterone receptor positivity supports hormonal control of syringomas, J Cutan Pathol 1995; 22:442-5.

9. Friedman SJ y Butler DF, Syringoma presenting as milia, J Am Acad Dermatol 1987; 16:310-4.

10. Bouyahyaoui Y, Meziane M, Bennani A, Gallouj S, Mikou O, Harmouch T, Amarti A y Mernissi FZ, Syringoma eruptif generalise, Ann Dermatol Venereol 2012; 139:508-9.

11. Fernández-Crehueta P, Herrera-Savala A, Domínguez-Cruza J y Camacho FM, Siringomas generalizados. Aportación de un caso. Generalized syringoma: a case study, Actas Dermosifiliogr 2007; 98:575-6.

12. Müller CS, Tilgen W y Pföhler C, Clinicopathological diversity of syringomas: a study on current clinical and histopathologic concepts, Dermato Endocrinol 2009; 1:282-8.

13. Lee JH, Chang JY y Lee KH, Syringoma: a clinicopathologic and immunohistologic study and results of treatment, Yonsei Med J 2007; 48:35-40.

14. Martínez-Luna E, Salazar-Rojas E, Rodríguez-Lobato E, Vega-Memije ME y Toussaint-Caire S, Quiz. Siringoma de células claras, dcmq 2015; 13(2):134-5.

15. Yoshimi N, Kurokawa I, Kakuno A, Tsubura A y Yamanishi K, Case of generalized eruptive clear cell syringoma with diabetes mellitus, J Dermatol 2011; 38:1-2.

16. Furue M, Hori Y y Nakabayashi Y, Clear-cell syringoma: association with diabetes mellitus, Am J Dermatopathol 1984; 6: 131-8.

17. Williams K y Shinkai K, Evaluation and management of the patient with multiple syringomas: a systematic review of the literatura, J Am Acad Dermatol 2016; 74:1234-40.

18. Hasson A, Farías MM, Nicklas C y Navarrete C, Periorbital syringoma treated with radiofrecuency and carbon dioxide (CO2) laser in 5 patients, J Drugs Dermatol 2012; 11:879-80.

19. Cho SB, Kim HJ, Noh S, Lee SJ, Kim YK y Lee JH, Treatment of syringoma using on ablative 10 600 nm carbon dioxide fractional laser: a prospective analysis of 35 patients, Dermatol Surg 2011; 37:433-8.